Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Dr. Michael Beehner recommends a personalized, careful approach to hairline design in hair replacement surgery for a natural look.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

AMT may cause hair loss and changing dWAT activity could help treat it.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

Low androgen levels can still cause female pattern hair loss.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Hair loss caused by genetics and hormones; more research needed for treatments.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

PRP injections increase hair density and diameter in female androgenetic alopecia patients.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Minoxidil foam helps hair growth by increasing good proteins and decreasing bad pathways in men with hair loss.

Gene differences found in hair follicles linked to male baldness.

Finasteride-loaded ethosomes improve hair loss treatment by targeting pilosebaceous unit.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Hair loss in Androgenetic Alopecia is not caused by damage to follicular stem cells.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.